Latest News in the pharma Industry
Research & Development
Chemotherapy as a tablet instead of an intravenous infusion
28 Mar 2017
New production method for solid dispersions of docetaxel and paclitaxel.
Read more
Encouraging results of Phase IIa study with Evenamide in patients with schizophrenia
27 Mar 2017
Unique mechanism: glutamate modulation and voltage-gated sodium channel blockade.
Read more
Eprex marketing authorisation extended to include treatment of symptomatic anaemia
27 Mar 2017
French Health Authority ANSM grants approval in the Mutual Recognition Procedure; the relevant health authorities are required to implement the new indication within 30 days.
Read more
Pfizer receives positive CHMP opinion for Trumenba for prevention of meningococcal group B disease
27 Mar 2017
Trumenba has been studied in a global clinical development program evaluating the vaccine in adolescents and adults.
Read more
Uninterrupted Pradaxa showed less major bleeding than warfarin in atrial fibrillation patients
20 Mar 2017
Patients studied in the trial were reflective of those undergoing catheter ablation in routine clinical practice, providing highly relevant data to treating physicians.
Read more
AstraZeneca study shows SGLT-2 inhibitors significantly reduced hospitalizations for heart failure and death
20 Mar 2017
Landmark real-world evidence from an international study of more than 300,000 patients with type-2 diabetes showed treatment with SGLT-2 inhibitors reduced risk of hospitalization for heart failure by 39% and all-cause mortality by 51%.
Read more
Apogenix presents data on novel Hexavalent TNF receptor agonists
20 Mar 2017
Agonists for GIT, CD27 and CD40 receptors in development for cancer immunotherapy exhibit significant in vitro- and in vivo activities.
Read more
New analysis shows Novartis Entresto improves glycemic control among heart failure patients with diabetes
19 Mar 2017
New use of insulin was also reduced by 29% among patients taking Entresto compared to enalapril-treated patients.
Read more
Dementia Consortium funds Manchester-based team targeting immune system in search for new dementia treatments
19 Mar 2017
Team led by Dr David Brough awarded £191,757 by public-private initiative driving early-stage drug discovery programmes.
Read more
Landmark outcomes study shows that Repatha decreases LDL-C to unprecedented low levels
17 Mar 2017
Amgen has announced that the 27,564-patient Repatha (evolocumab) cardiovascular outcomes study, FOURIER, established for the first time that maximally reducing low-density lipoprotein cholesterol (LDL-C) levels with Repatha, beyond what is possible wit...
Read more
FDA approves Novartis' Kisqali as first-line treatment for HR+/HER2- metastatic breast cancer
16 Mar 2017
Kisqali plus letrozole showed treatment benefit across all patient subgroups regardless of disease burden or tumour location.
Read more
Merck's Keytruda receives FDA approval to treat patients with refractory classical Hodgkin lymphoma
15 Mar 2017
Only anti-PD-1 therapy approved for the treatment of patients with difficult-to-treat cHL regardless of prior stem cell transplantation or use of brentuximab vedotin
Read more